Search - tctmd.com

Displaying 1 - 20 of 37

Sort: Relevancy | Date

News Daily News

Absorb BVS Meets Performance Goal in Diabetic Patients, but Is It Enough to Justify a Broader Label?

Yael L. Maxwell

December 23, 2016

News Industry News

Positive Five-Year Clinical Data from Micell Technologies’ MiStent Presented at TCT 2016

November 03, 2016

News Conference News TCT 2016

New BRS Studies Show Promise for Second-Generation Devices With Thinner Struts

Yael L. Maxwell

October 31, 2016

News Conference News TCT 2016

LEADERS FREE: Polymer-Free DES Maintains Superior Safety, Efficacy Over BMS at 2 Years

Yael L. Maxwell

October 30, 2016

News Features

精益求精：创新支架技术值得继续探索

Todd Neale

November 08, 2015

News Features

La Innovación en Tecnologías Stent es Posible y algo que Merece la Pena Perseguir

Todd Neale

November 08, 2015

News Features

From Great to Greater: Innovation in Stent Technology Possible, Worth Pursuing

Todd Neale

November 08, 2015

News Daily News

¿Adiós SMD? Nuevos Análisis de la DAPT Evidencian Menos Ocurrencias de Trombosis del Stent Con el SLF

Yael L. Maxwell

October 26, 2015

News Daily News

Goodbye BMS? New DAPT Analysis Shows Less Stent Thrombosis With DES

Yael L. Maxwell

October 26, 2015

Presentation

Stent Thrombosis in DES or BMS in Patients Receiving Dual Antiplatelet Therapy

Presenter: Dean J. Kereiakes

October 22, 2015

News Conference News TCT 2015

ABSORB III: Novel Bioresorbable Scaffold as Good as Standard-of-Care DES

Yael L. Maxwell

October 12, 2015

News Industry News

ABSORB III: Clinical Trial Demonstrates That A Bioresorbable Scaffold Is Non-Inferior To A Drug-Eluting Stent In Patients With Coronary Artery Disease

October 12, 2015

News Conference News AHA 2014

Biodegradable-Polymer DES Perform Well But Appear No Safer than Their Durable-Polymer Counterparts

November 18, 2014

News Industry News

New Data From EVOLVE Clinical Program Demonstrate SYNERGY™ Bioabsorbable Polymer Stent Meets Key Performance Endpoints

November 18, 2014

Presentation AHA 2014

Primary Outcomes of the EVOLVE II Trial: A Prospective Randomized Investigation of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent

Presenter: Dean J. Kereiakes

November 16, 2014

Presentation TCT 2014

BRS Under Development V Biolute BRS

Presenter: Alexandre Abizaid, Dean J. Kereiakes, Vasim Farooq, Dinesh Shah

September 16, 2014

Presentation TCT 2014

BRS Under Development IV The Lepu BRS

Presenter: Alexandre Abizaid, Dean J. Kereiakes, Vasim Farooq, Yaling Han

September 16, 2014

Presentation TCT 2014

BRS Under Development III The XINSORB BRS

Presenter: Alexandre Abizaid, Dean J. Kereiakes, Vasim Farooq, Junbo Ge

September 16, 2014

Presentation TCT 2014

BRS Under Development II Meril Life Sciences

Presenter: Alexandre Abizaid, Dean J. Kereiakes, Vasim Farooq, Martin B. Leon

September 16, 2014

Presentation TCT 2014

BRS Under Development I The Manli Mirage BRS

Presenter: Alexandre Abizaid, Dean J. Kereiakes, Vasim Farooq, Teguh Santoso

September 16, 2014

Advertisement

Absorb BVS Meets Performance Goal in Diabetic Patients, but Is It Enough to Justify a Broader Label?

Positive Five-Year Clinical Data from Micell Technologies’ MiStent Presented at TCT 2016

New BRS Studies Show Promise for Second-Generation Devices With Thinner Struts

LEADERS FREE: Polymer-Free DES Maintains Superior Safety, Efficacy Over BMS at 2 Years

精益求精：创新支架技术值得继续探索

La Innovación en Tecnologías Stent es Posible y algo que Merece la Pena Perseguir

From Great to Greater: Innovation in Stent Technology Possible, Worth Pursuing

¿Adiós SMD? Nuevos Análisis de la DAPT Evidencian Menos Ocurrencias de Trombosis del Stent Con el SLF

Goodbye BMS? New DAPT Analysis Shows Less Stent Thrombosis With DES

Stent Thrombosis in DES or BMS in Patients Receiving Dual Antiplatelet Therapy

ABSORB III: Novel Bioresorbable Scaffold as Good as Standard-of-Care DES

ABSORB III: Clinical Trial Demonstrates That A Bioresorbable Scaffold Is Non-Inferior To A Drug-Eluting Stent In Patients With Coronary Artery Disease

Biodegradable-Polymer DES Perform Well But Appear No Safer than Their Durable-Polymer Counterparts

New Data From EVOLVE Clinical Program Demonstrate SYNERGY™ Bioabsorbable Polymer Stent Meets Key Performance Endpoints

Primary Outcomes of the EVOLVE II Trial: A Prospective Randomized Investigation of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent

BRS Under Development V Biolute BRS

BRS Under Development IV The Lepu BRS

BRS Under Development III The XINSORB BRS

BRS Under Development II Meril Life Sciences

BRS Under Development I The Manli Mirage BRS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content